Biosimilars - Evidence issues

Activity: Talk or presentation typesInvited talk

Description

Amgen Australia Biosimilar Advisory Board
Period5 May 2017
Held atAmgen Australia Pty. Ltd., Australia
Degree of RecognitionNational